Deina H. Walsh, Chief Financial Officer at Bone Biologics Corp (BBLG), bought 8,000 shares at $0.64 ($5K) on 2023-09-13, disclosed to the SEC on 2023-09-14.
Open-market purchase of $5k BBLG by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Several strong factors at once. The rarest rating we give.